La neuropathie sensitive et motrice héréditaire avec agénésie du corps calleux (NSMH/ACC) se traduit par une atteinte neurodégénérative sévère associée à des anomalies développementales dans le système nerveux central et du retard mental. Bien que rare dans le monde, ce désordre autosomique récessif est particulièrement fréquent dans la population Québécoise du Canada Français du fait d’un effet fondateur. L’unique étude réalisée sur la mutation québécoise du gène qui code pour le co-transporteur de potassiumchlore 3 (KCC3) a montré qu’il y a une perte de fonction de la protéine. Cependant, la maladie est également retrouvée hors du Québec et il reste encore à élucider les pathomécanismes mis en jeu. Nous avons donc séquencé les 26 exons du gène KCC3 chez des individus recrutés dans le monde entier et suspectés d’être atteints de la maladie. Nous avons ainsi identifié trois nouvelles mutations. L’étude fonctionnelle de ces mutations nous a confirmé la perte de fonction systématique des co-transporteurs mutés. Puisque l’inactivation de KCC3 se produit majoritairement via l’élimination de segments peptidiques en C-terminus, nous avons concentré notre attention sur l’identification des interactions qui s’y produisent. À l’aide d’approches double hybride, pull-down et immunomarquage, nous avons déterminé que KCC3 interagit avec la créatine kinase CK-B et que cette interaction est perturbée par les mutations tronquantes. De plus, l’utilisation d’un inhibiteur de créatine kinase inactive KCC3, ce qui démontre qu’il existe bien un lien fonctionnel et pathologique entre KCC3 et ses partenaires C-terminaux. Nous avons aussi identifié des anomalies majeures de localisation membranaire des KCC3 mutés. Que KCC3 soit tronqué ou pleine longueur, sa distribution subcellulaire est affectée dans des cellules en culture, dans les ovocytes de Xenopes et dans des échantillons de cerveau de patients. La perte d’interaction entre KCC3 et CK-B et/ou les défauts de transit intracellulaire de KCC3 sont donc les mécanismes pathologiques majeurs de la NSMH/ACC. / Heredirary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC) is a severe neurodegenerative disease associated with developmental anomalies in the central nervous system and mental retardation. Although rare worldwide, this autosomal-recessive disorder is frequent in the French-Canadian population of Quebec because of a founder effect. Different mutations in the gene coding for the potassiumchloride co-transporter 3 (KCC3) have been associated with the disease; however, little is known about the mechanisms leading to the inactivation of the co-transporter. We sequenced 26 exons of the KCC3 gene in individuals recruited worldwide and suspected to be affected by the disease. We identified three new mutations. The functional study of these mutations gave confirmation of a systematic loss-of-function of the mutant co-transporters. As the loss of function occurs mainly via the elimination of C-terminal peptide fragments, we focused on the identification of C-terminal interacting partners. Using different biochemical approaches, such as yeast two-hydbrid, pull-down, and immunostaining, we established that KCC3 interacts with the brain-type creatine kinase CK-B and that this interaction is disrupted by the HMSN/ACC truncation mutations. In addition, a specific creatine kinase inhibitor inactivates KCC3 and shows for the first time the functional link between KCC3 and its C-terminal partners. In addition, we found that anomalies in KCC3 transit—as seen in cultured cells, in Xenopus oocytes, and in human brain samples—is a major pathogenic mechanism that also leads to the disease manifestations.

Proteins in Escherichia coli were compared in terms of essentiality, centrality, and conservation. The hypotheses of this study are: for proteins in Escherichia coli, (1) there is a positive, measureable correlation between protein conservation and essentiality, (2) there is a positive relationship between conservation and degree centrality, and (3) essentiality and centrality also have a positive correlation. The third hypothesis was supported by a moderate correlation, the first with a weak correlation, and the second hypotheis was not supported. When proteins that did not map to orthologous groups and proteins that had no interactions were removed, the relationship between essentality and conservation increased to a strong relationship. This was due to the effect of proteins that did not map to orthologus groups and suggests that protein orthology represented by clusters of orthologus groups does not accurately dipict protein conservation among the species studied.

English Abstract The incoming paradigm of the network (or systems) biology calls for a new high throughput tool for a wide scale study of protein-protein interactions. Mass spectrometry-based proteomics have experienced a great progress in recent years and have become an indispensable technology of elementary as well as clinical research. Glutamate carboxypeptidase II (GCPII; EC 3.5.17.21) is a transmembrane protein with two known enzymatic activities. Its expression is highly upregulated in some solid tumors and also in tumor-associated neovasculature in general. Nevertheless, none of the two enzymatic activities were shown to be physiologically relevant to these cells. Some facts point at a possible receptor function of GCPII, however, no specific binding partner has been found yet. In the search for potential binding partners and/or ligands of GCPII, a series of methods have been employed, including pull-down experiment, immunoprecipitation and mass spectrometry. Sample preparation and mass spectrometry data processing methodology was specifically developed in order to identify potential binding partners. As one of the outcome of that methodology, the interaction of β-subunit of F1 ATP synthase was selected for further detailed analysis as a putative ligand of GCPII.

Les Sémaphorines de classe 3 modulent de nombreux comportement neuritiques lors de la formation du système nerveux central. Leur liaison sur des complexes récepteurs composés de la sous unité obligatoire de liaison au ligand, les Neuropilines1,2 (Nrp1,2) et de la sous unité de signalisation, les PléxinesA1-4, permet d'assurer la spécificité fonctionnelle. Cependant, les mécanismes moléculaires contrôlant la formation de ces complexes récepteurs ne sont pas connus. Au cours de ma thèse, j'ai étudié l'assemblage des complexes récepteurs des Sémaphorines de classe 3 par une approche FRET. J'ai pu montrer que Nrp1,2 forment des homo et hétéro-oligomères à la membrane plasmique. Nrp1 peut former des hétero-oligomères avec les PléxinesA1,2 et 4 mais apparemment pas avec PléxineA3. La délétion du domaine Séma de PléxineA3 (PléxinesA3∆sem) suffit pour induire la formation d'hétéro-complexes Nrp1-PléxinesA3∆sem. Ces résultats suggèrent que le domaine Séma de PléxineA3 adopte une conformation différente des autres PléxinesA et empêche l'interaction entre PléxineA3 et Nrp1. De plus, toutes les PléxinesA peuvent former des homo-oligomères de manière indépendante du domaine Séma. Ces résultats suggèrent que les récepteurs des Sémaphorines de classe 3 pourraient former des complexes oligomériques plus important, composés d'homo-dimères de Nrps et de PléxinesA. Dans la deuxième partie de ma thèse, j'ai étudié la spécificité de signalisation des PléxinesA dans les interneurones GABAergiques du cervelet. Au laboratoire, nous avons montré que Séma3A induit la formation de branches des interneurones GABAergiques du cervelet par l'intermédiaire de Fyn. Mais l'identité des complexes récepteurs Séma3A impliquée dans ce processus n'était pas connue. Nous avons montré que les interneurones GABAergiques expriment PléxineA1,A2 A3 mais pas A4. Alors que les PléxinesA1,2 et 3 interagissent avec la protéine Fyn, seule l'activation des voies de signalisation de PléxineA1 et A2 induit la formation de branches in vitro. De manière intéressante, Fyn interagit avec les PléxinesA1 et A2 via son domaine SH3 alors qu'elle utilise son domaine SH2 pour l'interaction avec PléxineA3, suggérant l'importance du mode d'interaction de Fyn avec les PléxinesA pour sa fonction. Enfin nous avons pu montrer que PléxineA1 est la seule Pléxine in vivo capable d'induire un défaut de formation de branches des interneurones GABAergiques du cervelet. / Secreted class 3 Semaphorin (Sema3) modulates a wide variety of axon behavior during central nervous system formation. Sema3 family functions are triggered through binding to specific receptor complexes that include the obligate binding subunit Neuropilins-1 and 2 (Nrp1-2) and the signalling subunit plexin-A1-4. Yet, the exact mechanism controlling Sema3 receptor complex formation is not known. Here, we investigate Sema3 cell surface receptor formation using a time resolved FRET approach. We showed that Nrp-1 and 2 formed homo and hetero-oligomers at the cell surface of leaving cells. Nrp-1 can form hetero-oligomers with PlexinA1, A2 and A4 but not with PlexinA3. Deletion of the Plexin-Sema domain of PlexinA3 (PlexinA3∆sem) induced the formation of Nrp1 and PexinA3∆sem hetero-complexes. These results showed that PlexinA3-sema domain adopts a different conformation from the other PlexinAs and inhibited the interaction with Nrp1. Furthermore, PlexinAs can form homo-oligomers independently of the Plexin-Sema domain. These results further suggest that Sema3 receptors could form higher oligomeric complex that include homodimers of both neuropilins and PlexinAs. Understanding the basic principles of Sema3 receptor assembly will be pivotal to decipher how ligand binding translates into specific pathways of cellular signaling. In the second part of my thesis we investigated PlexinA specific signaling in cerebellar GABAergic interneurons. Sema3A induced GABAergic axonal branching in cerebellar cortex in a Fyn dependent manner (Cioni et al.,2013). However the identity of Sema3A receptor complexes involved in this process needed further investigation. We showed that PlexinA1, A2 and A3, but not PlexinA4, are expressed in GABAergic interneurons. While PlexinA1-3 are associated with FYN, only PlexinA1 and A2 induced axon branching. Interestingly, Fyn interaction with PlexinA1 and A2 is mediated via the SH3 domain while the interaction with PlexinA3 is through the SH2 domain, suggesting that the binding mode of Fyn to PlexinA is important. These results were further supported by in vivo characterization of PlexinA1-4 deficient mice that showed GABAergic axon branch deficit only in PlexinA1 mutant.

Les bactéries à Gram négatif sont entourées par une enveloppe cellulaire qui, contrairement aux bactéries à Gram positif, possèdent une organisation membranaire complexe composée d’une membrane interne appelée généralement membrane cytoplasmique, un espace périplasmique contenant une matrice de peptidoglycane et une membrane externe asymétrique constituée d’une monocouche de phospholipides surmontée d’une assise de lipopolysaccharide (LPS). Afin de franchir cette barrière, les bactéries à Gram négatif ont développé différentes voies de sécrétions spécifiques dédiées à l’export des protéines (effecteurs) du milieu intracellulaire vers le milieu extracellulaire. Jusqu'à présent, six systèmes de sécrétion ont été identifiés chez ces bactéries. Chez Pseudomonas aeruginosa, une bactérie pathogène opportuniste, le système de sécrétion de type II appelé aussi sécréton Xcp constitue l’un des facteurs principales de sa virulence. Le sécréton Xcp est un complexe macromoléculaire formé par 12 protéines, nommées XcpAO et XcpPC-XcpZM. Ce complexe macromoléculaire est organisé en trois sous-complexes : i) une plateforme d’assemblage ancrée dans la membrane interne formé par les protéines XcpRESFYLZM ii) un pore de sécrétion localisé dans la membrane externe formé par l’oligomérisation d’une protéine appelé la sécrétine XcpQD. Le pore de sécrétion est connecté à la plateforme de la membrane interne par une protéine appelée XcpPC iii) un pseudopilus périplasmique sous forme de fibre hélicoïdale qui est formé par la multimérisation d’une protéine appelée la pseudopiline majeure XcpTG. D’autres protéines appelées les pseudopilines mineures XcpUH-VI-WJ-XK intègrent le pseudopilus. La première partie du travail effectué au cours de cette thèse a eu pour but d’étudier et de comprendre par des approches structurales, biochimiques et biophysiques le mécanisme d’assemblage des pseudopilines en pseudopilus. La deuxième partie de ce travail a porté sur l’étude des réseaux d’interactions entre les substrats sécrétés et les composants de la machinerie Xcp. Durant cette thèse, nous avons ainsi i) identifier grâce à l’étude des interactions protéine-protéine l’existence d’un complexe quaternaire entre les pseudopilines mineures XcpUH-VI-WJ-XK localisées au sommet du pseudopilus ii) déterminer les structures de la pseudopiline majeure XcpTG par RMN et de la pseudopiline mineure XcpWJ par cristallographie aux rayons X iii) déterminer les différents éléments du sécréton qui interagissent avec les exoprotéines du sécréton. Ce réseau d’interaction nous a permis de proposer un modèle de fonctionnement du sécréton qui élucide le cheminement des exoprotéines dans le sécréton afin qu’elles soient exportées vers le milieu extracellulaire. / Gram-negative bacteria are characterized by a complex organization of their cell envelope composed by the inner membrane (IM) called cytoplasmic membrane, the periplasmic space containing a peptidoglycan layer and the outer membrane (OM) covered by the lipopolysaccharide matrix. Gram-negative bacteria have evolved several specialized machines called secretion systems to export their effectors from the intracellular medium to the extracellular milieu or to the host cells. Up to now, at least six secretion systems have been identified. In the opportunistic pathogen Pseudomonas aeruginosa, the type II secretion system called the Xcp secreton is the major pathway for the release of virulence factors. The Xcp secreton is a macromolecular complex composed by 12 proteins called XcpAO, XcpPC-XcpZM. This machinery is organized in 3 sub-complexes: i) the assembly platform localized in the IM implicating XcpRESFYLZM proteins ii) the OM pore composed by the oligomerization of the secretin XcpQD. The connection between the assembly platform and the secretin is performed by XcpPC anchored in the IM iii) a periplasmic pseudopilus consisting of the multimerization of the so-called major pseudopilin XcpTG. The pseudopilus is a helicoidally filament spanning the periplasmic area and pushing the substrate into the secretin pore. Four other proteins, the minor pseudopilins XcpUH-VI-WJ-XK, were found in the pseudopilus. In the present work we first focused on the study of the pseudopilus components by biochemical, biophysical and structural strategies to understand their assembly. Secondly, we investigate the protein interactome between periplasmic secreton component and secreted substrates. Thus, we revealed the presence of a quaternary complex composed by XcpUH-VI-WJ-XK located at the tip of the pseudopilus. To understand at atomic scale the regulation of the pseudopilus, we determined the structure of two components of the pseudopilus XcpTG by NMR and XcpWJ by X-ray crystallography. Using systematic protein-protein interaction studies between secreton components and purified exoproteins of Pseudomonas aeruginosa, we identified 5 proteins of the secreton able to interact with exoproteins. This interaction network allowed us to propose a model for the secretion process including the sequential steps followed by exoproteins inside the secreton to leave the cell envelop.

Mon travail de thèse s'est focalisé sur la machinerie enzymatique impliquée dans la réplication du génome ARN du Syndrome Respiratoire Aigu Sévère-Coronavirus (SRAS-CoV). J'ai montré in vitro que l'activité ARN polymérase ARN-dépendante (RdRp) portée par nsp12 nécessite le complexe nsp7/nsp8, qui agit comme facteur de processivité. Grâce à ce complexe polymérase hautement actif, j'ai pu en suite étudier le mécanisme de "proofreading" (correction d'épreuve) associé aux coronavirus, pour lequel seulement des preuves indirectes avaient été assemblées. En effet, les coronavirus codent pour une activité exonucléase 3'-5' (nsp14-ExoN) qui lorsqu'elle est absente, entraine 14-fois plus d'erreurs de réplication en contexte cellulaire. In vitro, nous avons pu montrer que nsp14-ExoN est capable d'exciser l'ARN double brin ainsi qu'un nucléotide mésapparié en 3' de l'ARN en cours d'élongation. J'ai pu apporter pour la première fois une preuve directe de l'existence d'un système de réparation des erreurs au cours de la synthèse, mené par le complexe nsp7/nsp8/nsp12/nsp14. En effet, le complexe nsp7/nsp8/nsp12 ralentit jusqu'à 30-fois quand il rajoute une base mésappariée. Par sequençage, nous avons pu montrer la réparation de cette base mésappariée en presence de nsp14. Enfin, grâce à ce système in vitro nous avons une base pour comprendre l'inefficacité de la ribavirine sur des patients atteints du SRAS. En effet, la ribavirine, incorporée par le complexe polymérase, serait également excisée par nsp14, annihilant tout potentiel effet mutagenique. En conclusion, ce système va permettre de guider le développement d'antiviraux de type nucleoside analogues contre les coronavirus. / This work focused on the enzymatic machinery involved in Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) RNA replication and transcription. Firstly, I established a robust in vitro polymerase assay with the canonical SARS-CoV RNA-dependent RNA polymerase (RdRp) nsp12. I showed that nsp12, in order to engage processive RNA synthesis, needs two viral proteins, i.e. nsp7 and nsp8. This nsp7/nsp8 complex not only activates nsp12-RdRp, but also acts as a processivity factor. Thus, using this processive polymerase complex, I could investigate SARS-CoV proofreading for which only indirect evidences were reported. Indeed, coronaviruses encode for a 3'-5' exonuclease (nsp14-ExoN), putatively involved in a mechanism that proofreads coronavirus RNA during viral replication. We first showed in vitro that nsp14-ExoN, which is stimulated by nsp10, is able to excise specifically dsRNA as well as all primer/templates bearing a 3' mismatch on the primer. Moreover, we could confirm by sequencing that a RNA 3' mismatch was indeed corrected in vitro by the nsp7/nsp8/nsp12/nsp14 complex. We provide for the first time direct evidence that nsp14-ExoN, in coordination with the polymerase complex, is able to proofread RNA. Interestingly, using this in vitro system we found an element that could possibly explain the inefficacy of ribavirin therapeutic treatment on SARS-patients: ribavirin, which is incorporated by the SARS-CoV polymerase complex, would also be excised by nsp14. In conclusion, this system will drive future development of antivirals, particularly of the nucleoside analogue type, against coronaviruses.

Le cancer de la prostate représente la deuxième cause de décès liée au cancer. Des stratégies thérapeutiques ciblant des mécanismes moléculaires conduisant à la résistance doivent donc être développées. Une stratégie visant à améliorer les traitements du cancer de la prostate consiste à cibler les gènes qui sont activés lors de la disparition des androgènes, soit pour retarder ou empêcher l'émergence du phénotype de résistance à la castration. Le but de cette thèse est d'identifier et de développer des petites molécules inhibitrices ciblant des interactions protéine-protéine impliquées dans le cancer de la prostate. Cette thèse porte sur l'étude de deux protéines cruciales liées au cancer de la prostate, à savoir, la protéine de choc thermique de bas poids moléculaire (Hsp27) et la protéine TCTP. Nous avons validé deux composés ciblant TCTP en utilisant une chimiothèque dédiée à l'inhibition d'interaction protéine-protéine. Des tests fonctionnels sont actuellement mis au point pour évaluer la capacité de ces molécules à être proposées comme composés potentiels contre le cancer de la prostate. / Prostate Cancer (PCa) is one of most common malignancies, being the second leading cause among cancer-related death. Additional therapeutic strategies targeting molecular mechanisms mediating resistance must be developed because of the defects of docetaxel-based treatments. One strategy to improve therapies in advanced PCa involves targeting genes that are activated by androgen withdrawal, either to delay or prevent the emergence of the CR phenotype. The purpose of my thesis is to identify & develop small molecules inhibitors targeting PPIs involved in prostate cancer. we focuses on 2 crucial prostate cancer related proteins, namely, the small molecular weight Heat shock protein 27 (Hsp27) and the Translationally Controlled Tumor Protein (TCTP). We have validated 2 compounds targeting TCTP by using a "PPI Inhibitor-like" dedicated chemical library. Functional tests are now being developed to evaluate the capacity of such molecules to be proposed as potential compounds against prostate cancer.

No description available.

A comprehensive understanding of physiological role of proteins requires knowledge of their three-dimensional structure, dynamics and protein-protein interactions. Chemical cross-linking in combination with mass spectrometry represents an alternative approach to standard methods for protein structure elucidation (X-ray crystalography, NMR spectroscopy) and enables characterization of interaction interface within protein complexes in their native states. The presented thesis is mainly focused on novel cross-linking methodology based on the in vivo incorporation of methionine analog with photo-reactive functional group (photo-Met) into the sequence of studied protein (so called protein photo-nanoprobe). Interaction between two molecules of 14-3-3zeta protein was used as a model to test and optimize the protein photo-nanoprobe production. The findings confirmed usefulness of this approach for mapping the protein-protein interactions. The photo-initiated cross-linking was used to detect the heterooligomeric membrane structures of cytochromes P450 2B4 and b5 and the molar ratio of cytochromes within individual complexes was assessed. The chemical cross-linking in combination with mass spectrometry was employed to characterize the interaction of their catalytic domains and two mutual orientations of...

Doenças complexas são caracterizadas por serem poligênicas e multifatoriais, o que representa um desafio em relação à busca de genes relacionados a elas. Com o advento das tecnologias de sequenciamento em larga escala do genoma e das medições de expressão gênica (transcritoma), bem como o conhecimento de interações proteína-proteína, doenças complexas têm sido sistematicamente investigadas. Particularmente, baseando-se no paradigma Network Medicine, as redes de interação proteína-proteína (PPI -- Protein-Protein Interaction) têm sido utilizadas para priorizar genes relacionados às doenças complexas segundo suas características topológicas. Entretanto, as redes PPI são afetadas pelo viés da literatura, em que as proteínas mais estudadas tendem a ter mais conexões, degradando a qualidade dos resultados. Adicionalmente, métodos que utilizam somente redes PPI fornecem apenas resultados estáticos e não-específicos, uma vez que as topologias destas redes não são específicas de uma determinada doença. Neste trabalho, desenvolvemos uma metodologia para priorizar genes e vias biológicas relacionados à uma dada doença complexa, através de uma abordagem integrativa de dados de redes PPI, transcritômica e genômica, visando aumentar a replicabilidade dos diferentes estudos e a descoberta de novos genes associados à doença. Após a integração das redes PPI com dados de expressão gênica, aplicamos as hipóteses da Network Medicine à rede resultante para conectar genes sementes (relacionados à doença, definidos a partir de estudos de associação) através de caminhos mínimos que possuam maior co-expressão entre seus genes. Dados de expressão em duas condições (controle e doença) são usados separadamente para obter duas redes, em que cada nó (gene) dessas redes é pontuado segundo fatores topológicos e de co-expressão. Baseado nesta pontuação, desenvolvemos dois escores de ranqueamento: um que prioriza genes com maior alteração entre suas pontuações em cada condição, e outro que privilegia genes com a maior soma destas pontuações. A aplicação do método a três estudos envolvendo dados de expressão de esquizofrenia recuperou com sucesso genes diferencialmente co-expressos em duas condições, e ao mesmo tempo evitou o viés da literatura. Além disso, houve uma melhoria substancial na replicação dos resultados pelo método aplicado aos três estudos, que por métodos convencionais não alcançavam replicabilidade satisfatória. / Complex diseases are characterized as being poligenic and multifactorial, so this poses a challenge regarding the search for genes related to them. With the advent of high-throughput technologies for genome sequencing and gene expression measurements (transcriptome), as well as the knowledge of protein-protein interactions, complex diseases have been sistematically investigated. Particularly, Protein-Protein Interaction (PPI) networks have been used to prioritize genes related to complex diseases according to its topological features. However, PPI networks are affected by ascertainment bias, in which the most studied proteins tend to have more connections, degrading the quality of the results. Additionally, methods using only PPI networks can provide just static and non-specific results, since the topologies of these networks are not specific of a given disease. In this work, we developed a methodology to prioritize genes and biological pathways related to a given complex disease, through an approach that integrates data from PPI networks, transcriptomics and genomics, aiming to increase replicability of different studies and to discover new genes associated to the disease. The methodology integrates PPI network and gene expression data, and then applies the Network Medicine Hypotheses to the resulting network in order to connect seed genes (obtained from association studies) through shortest paths possessing larger coexpression among their genes. Gene expression data in two conditions (control and disease) are used to obtain two networks, where each node (gene) in these networks is rated according to topological and coexpression aspects. Based on this rating, we developed two ranking scores: one that prioritizes genes with the largest alteration between their ratings in each condition, and another that favors genes with the greatest sum of these scores. The application of this method to three studies involving schizophrenia expression data successfully recovered differentially co-expressed gene in two conditions, while avoiding the ascertainment bias. Furthermore, when applied to the three studies, the method achieved a substantial improvement in replication of results, while other conventional methods did not reach a satisfactory replicability.